The global histology and cytology market size is expected to be worth around US$ 47.7billion by 2030, according to a new report by Vision Research Reports.
The global histology and cytology market size is expected to be worth around US$ 47.7billion by 2030, according to a new report by Vision Research Reports.
The global histology and cytology market size was valued at US$ 24.1 billion in 2020 and is anticipated to grow at a CAGR of 13.10% during forecast period 2021 to 2030.
Immediate Delivery Available | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/37626
Growth Factors
The factors contributing to market growth include increasing incidence of cancer, development of advanced tools for early disease diagnosis, implementation of immunohistochemistry, and innovation in microscopy.
In addition, organizations are collaborating for the standardization of cytopathology across the world, which is driving the market. For instance, in May 2020, International Agency for Research on Cancer (IARC) entered in collaboration with The International Academy of Cytology (IAC) for publishing a series of cytopathology reporting systems, for presenting an international approach that can be used for cytopathology of different body sites. The two organizations are engaged in the expansion and development of internationally recognized diagnostic reports for cancer and other precancerous disorders worldwide.
Moreover, companies are launching new and automated instruments for cytology which can be further attributed to the market growth. For instance, ELITechGroup Inc., in March 2020, launched Aerospray Cytology Slide Stainer Cytocentrifuge. It helps in the automation of the staining and preparation of specimens that are used in liquid-based cytology for facilitating the investigation of a collection of cell differentiation by using Papanicolaou staining techniques.
Report Highlights
The cytology segment dominated the market for histology and cytology and held the largest revenue share of 67.8% in 2020 and is expected to continue the trend during the forecast period. The integration of Artificial Intelligence (AI) for developing advanced cytology systems can be attributed to segment growth. For instance, in November 2020, Hologic, Inc. launched CE marked received Genius Digital Diagnostics System that combines artificial intelligence (AI) algorithm for offering digital imaging solutions to pathologists and cytotechnologists.
The system consists of an AI algorithm for efficient analysis of images, a digital imager system that helps in image acquisition, an image management server, and a reviewing station for a case review. Cervical cancer accounted for the largest share of 36.4% of the cytology segment revenue in 2020. According to WHO, the annual number of cervical cancer new cases is expected to rise from around 570,000 to 700,000 from 2018 to 2030.
Low- and middle-income countries particularly create a favorable environment for the emerging industry participants keen on establishing market presence; this is attributed to a comparatively high incidence of cancer. Hence, for reducing the mortality rate effective screening methods and early detection of Human Papillomavirus (HPV) are essential.
The WHO has recommended Papanicolaou cytology (Pap smear) for cervical cytology screening as it has the ability to detect precursor lesions of cervical cancer at low cost, with flexibility, and at high rates. Hence, an increase in the employment of innovative cytology solutions in cervical cancer screening is set to contribute to the growth of the market for histology and cytology.
Advanced histology technologies have improved the workflow by speeding up the diagnostic capabilities of clinical laboratories. Moreover, companies are focusing on integrating AI platforms in histology. For instance, in September 2020, Cernostics in collaboration with Deciphex evaluated the use of AI technology-based image analysis tools for facilitating early detection of cancer in patients with Barrett's esophagus.
The consumables and reagents segment dominated the market for histology and cytology and held the largest revenue share of 58.9% in 2020. The segment is expected to continue its dominance from 2021 to 2028. Several consumables are used for the histology and cytology process such as tissue sample containers, kits, stain reagents, fixative solutions, medium reagents, and other reagents. The large share of the segment can be primarily attributed to the routine adoption of histology and cytology consumables.
In addition, companies are developing cost-effective kits and reagents, further driving the market for histology and cytology. For instance, in August 2020, Biocare Medical LLC in collaboration with Bethyl Laboratories released the TIGIT [BLR047F] antibody, a new rabbit monoclonal antibody, for qualitative identification of the TIGIT protein by using Immunohistochemistry (IHC). The antibody will be a cost-effective immunohistochemistry solution for pharmaceutical and biotech research institutions.
Instruments and analysis software system is expected to grow through 2021 to 2028 owing to increasing application of technologically advanced instruments such as multimodal nonlinear microscopy, photoacoustic microscopy and stimulated Raman spectroscopy for histopathology. However, the significant infrastructure costs, along with technical and practical limitations in the pathology industry have affected the adoption of such large-scale digital transformative solutions. Hence, the reduction in the cost of the digitization process will improve the rate of digital adoption in pathology.
The drug discovery and designing segment dominated the market for histology and cytology and accounted for the largest revenue share of 44.9% in 2020. The segment is expected to continue its dominance over the forecast period. The growth in the segment can be attributed to the wide use of histomorphometry and IHC staining in pharmaceutical and biotechnology companies for drug development. The image analysis is applied across several steps of drug discovery and development such as drug efficacy and safety studies, target validation, drug repositioning, patient stratification, and biomarker expression studies.
The clinical diagnostics segment is expected to witness a CAGR of 12.6% over the forecast period owing to the increasing application of histopathology studies for the diagnosis of different types of cancer. The cells and tissues are removed from suspicious lump sites for identifying abnormalities and malignancy. They are widely used for screening various types of cancers such as breast, bowel, and cervical cancer.
North America dominated the histology and cytology market and accounted for the largest revenue share of 41.4% in 2020. This growth in the region can be attributed to several factors such as high incidence of cancer, extensive R&D activities, presence of key players, and established research infrastructure for pathology services. In addition, the high rate of product approval and commercialization in the region is further contributing to the growth of the market for histology and cytology.
In the Asia Pacific, the market for histology and cytology is expected to witness the fastest growth rate of 14.5% from 2021 to 2028. The growth in the region is due to several factors such as rising cancer awareness, a large target population, and improving healthcare infrastructure. In addition, researchers are increasingly evaluating new cytology which is further fueling the growth of the market for histology and cytology in the region.
For instance, in February 2020, researchers in Japan evaluated the efficacy of liquid-based cytology over conventional cytology in cervical cancer screening. The results of the study indicated that liquid-based cytology was comparatively more useful than conventional cytology from practical standpoints.
Related Reports
- Multiplex Assay Market Report 2022-2030 - https://www.visionresearchreports.com/multiplex-assay-market/39755
- Supply Chain Management Market Report 2022-2030 - https://www.visionresearchreports.com/supply-chain-management-market/39920
- Artificial Intelligence As A Service Market Report 2022-2030 - https://www.visionresearchreports.com/artificial-intelligence-as-a-service-market/39918
Key Players
- Hologic, Inc.
- Abbott
- Becton, Dickinson and Company
- F. Hoffmann-La Roche Ltd
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Danaher
- Sysmex Corporation
- Trivitron Healthcare
- Koninklijke Philips N.V.
Market Segmentation
- Type Of Examination Outlook
- Histology
- By Technique
- Microscopy
- Immunohistochemistry
- Molecular pathology
- Cryostat & Microtomy
- By Technique
- Cytology
- By Technique
- Microscopy
- Immunohistochemistry
- Molecular pathology
- Cryostat & Microtomy
- By Application
- Breast Cancer
- Cervical Cancer
- Bladder Cancer
- Lung Cancer
- Other Cancers
- By Technique
- Histology
- Product Outlook
- Instruments and Analysis Software System
- Consumable and Reagents
- Application Outlook
- Drug Discovery & Designing
- Clinical Diagnostics
- Research
- Regional Outlook
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Click Here to View Full Report Table of Contents
Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/checkout/37626
You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://qyresearchmedical.com/